Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder

Journal of Anxiety Disorders

Volumn 34, Issue , 2015, Pages 63-67

  de Kleine, Rianne A ^a,b   Smits, Jasper A J ^c   Hendriks, Gert Jan ^a,b,d   Becker, Eni S ^b   van Minnen, Agnes ^a,b  

^a Pro Persona Centre for Integrative Mental Health Care   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

D cycloserine; Extinction learning; Moderation; Posttraumatic stress disorder

Indexed keywords

CYCLOSERINE; PLACEBO; ANXIOLYTIC AGENT;

ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; DRUG EFFICACY; EXPOSURE THERAPY; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REINFORCEMENT; SELF REPORT; ANXIETY DISORDERS; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; LEARNING; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; CYCLOSERINE; DOUBLE-BLIND METHOD; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; HUMANS; IMPLOSIVE THERAPY; LEARNING; MALE; SELF REPORT; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 84932603648     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2015.06.005     Document Type: Article

References (39)

1. Bluett E.J., Zoellner L.A., Feeny N.C. Does change in distress matter? Mechanisms of change in prolonged exposure for PTSD. Journal of Behavior Therapy and Experimental Psychiatry 2014, 4(1):97-104. 10.1016/j.jbtep.2013.09.003.
2. Bolkan S.S., Lattal K.M. Opposing effects of d-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior. Neurobiology of Learning and Memory 2014, 113:25-34. 10.1016/j.nlm.2013.12.009.
3. Bontempo A., Panza K.E., Bloch M.H. d-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis. Journal of Clinical Psychiatry 2012, 73(4):533-537. 10.4088/JCP.11r07356.
4. Bouton M.E., Vurbic D., Woods A.M. d-cycloserine facilitates context-specific fear extinction learning. Neurobiology of Learning and Memory 2008, 90(3):504-510. 10.1016/j.nlm.2008.07.003.
5. Bremner J.D., Elzinga B., Schmahl C., Vermetten E. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Progress in Brain Research 2008, 167:171-186. 10.1016/s0079-6123(07)67012-5.
6. Davis M., Ressler K., Rothbaum B.O., Richardson R. Effects of d-cycloserine on extinction: translation from preclinical to clinical work. Biological Psychiatry 2006, 60(4):369-375. 10.1016/j.biopsych.2006.03.084.
7. de Kleine R.A., Hendriks G.J., Kusters W.J., Broekman T.G., van Minnen A. A randomized placebo-controlled trial of d-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry 2012, 71(11):962-968. 10.1016/j.biopsych.2012.02.033.
8. de Kleine R.A., Hendriks G.J., Smits J.A., Broekman T.G., van Minnen A. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research 2014, 48(1):40-46. 10.1016/j.jpsychires.2013.10.008.
9. Difede J., Cukor J., Wyka K., Olden M., Hoffman H., Lee F.S., et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology 2014, 39(5):1052-1058. 10.1038/npp.2013.317.
10. Foa E.B., Hembree E.A., Rothbaum B.O. Prolonged exposure therapy for PTSD: emotional processing of traumatic experiences: therapist guide 2007, Oxford University Press; US, New York, NY.
11. Foa E.B., Riggs D.S., Dancu C.V., Rothbaum B.O. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. Journal of Traumatic Stress 1993, 6(4):459-473.
12. Guastella A., Dadds M., Lovibond P., Mitchell P., Richardson R. A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear. Journal of Psychiatric Research 2007, 41(6):466-471. 10.1016/j.jpsychires.2006.05.006.
13. Hagenaars M.A., van Minnen A., Hoogduin K.A. The impact of dissociation and depression on the efficacy of prolonged exposure treatment for PTSD. Behaviour Research and Therapy 2010, 48(1):19-27. 10.1016/j.brat.2009.09.001.
14. Hofmann S.G. Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders. Clinical Psychology Review 2008, 28(2):199-210.
15. Hofmann S.G. d-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse. Depression and Anxiety 2014, 31(3):175-177. 10.1002/da.22257.
16. Hofmann S.G., Smits J.A., Asnaani A., Gutner C.A., Otto M.W. Cognitive enhancers for anxiety disorders. Pharmacology Biochemistry & Behavior 2011, 99(2):275-284. 10.1016/j.pbb.2010.11.020.
17. Ledgerwood L., Richardson R., Cranney J. Effects of d-cycloserine on extinction of conditioned freezing. Behavioral Neuroscience 2003, 117(2):341-349.
18. Lee J.L., Milton A.L., Everitt B.J. Reconsolidation and extinction of conditioned fear: inhibition and potentiation. The Journal of Neuroscience 2006, 26(39):10051-10056. 10.1523/jneurosci. 2466-06.2006.
19. Litz B.T., Salters-Pedneault K., Steenkamp M.M., Hermos J.A., Bryant R.A., Otto M.W., et al. A randomized placebo-controlled trial of d-cycloserine and exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research 2012, 46(9):1184-1190. 10.1016/j.jpsychires.2012.05.006.
20. Mol S.L., Arntz A., Metsemakers J.F.M., Dinant G.J., Vilters-Van Montfort P.A.P., Knottnerus J.A. Symptoms of post-traumatic stress disorder after non-traumatic events: evidence from an open population study. British Journal of Psychiatry 2005, 186(6):494-499. 10.1192/bjp.186.6.494.
21. Myers K., Davis M. Mechanisms of fear extinction. Molecular Psychiatry 2007, 12:120-150.
22. Norberg M., Krystal J., Tolin D. A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry 2008, 68:1118-1126.
23. Rauch S.A., Foa E.B., Furr J.M., Filip J.C. Imagery vividness and perceived anxious arousal in prolonged exposure treatment for PTSD. Journal of Traumatic Stress 2004, 17(6):461-465. 10.1007/s10960-004-5794-8.
24. Ressler K., Rothbaum B., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: use of d-Cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry 2004, 61:1136-1144.
25. Rodrigues H., Figueira I., Lopes A., Goncalves R., Mendlowicz M.V., Coutinho E.S., et al. Does d-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis. PLoS One 2014, 9(7):e93519. 10.1371/journal.pone.0093519.
26. Rothbaum B.O., Price M., Jovanovic T., Norrholm S.D., Gerardi M., Dunlop B., et al. A randomized, double-blind evaluation of d-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. American Journal of Psychiatry 2014, 171(6):640-648. 10.1176/appi.ajp.2014.13121625.
27. Scheeringa M.S., Weems C.F. Randomized placebo-controlled d-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress. Journal of Child and Adolescent Psychopharmacology 2014, 24(2):69-77. 10.1089/cap.2013.0106.
28. Siegmund A., Golfels F., Finck C., Halisch A., Räth D., Plag J., et al. d-Cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial. Journal of Psychiatric Research 2011, 45(8):1042-1047. 10.1016/j.jpsychires.2011.01.020.
29. Smits J.A., Rosenfield D., Davis M.L., Julian K., Handelsman P.R., Otto M.W., et al. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial. Biological Psychiatry 2014, 75(11):840-846. 10.1016/j.biopsych.2013.10.008.
30. Smits J.A., Rosenfield D., Otto M.W., Marques L., Davis M.L., Meuret A.E., et al. d-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. Journal of Psychiatric Research 2013, 47(10):1455-1461. 10.1016/j.jpsychires.2013.06.020.
31. Smits J.A., Rosenfield D., Otto M.W., Powers M.B., Hofmann S.G., Telch M.J., et al. d-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biological Psychiatry 2013, 73(11):1054-1058. 10.1016/j.biopsych.2012.12.009.
32. Telch M.J., Bruchey A.K., Rosenfield D., Cobb A.R., Smits J., Pahl S., et al. Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. American Journal of Psychiatry 2014, 171(10):1091-1098. 10.1176/appi.ajp.2014.13101407.
33. van Minnen A., Foa E.B. The effect of imaginal exposure length on outcome of treatment for PTSD. Journal of Traumatic Stress 2006, 19(4):427-438. 10.1002/jts.20146.
34. van Minnen A., Hagenaars M.A. Fear activation and habituation patterns as early process predictors of response to prolonged exposure treatment in PTSD. Journal of Traumatic Stress 2002, 15(5):359-367. 10.1023/A:1020177023209.
35. Walker D.L., Ressler K.J., Lu K.T., Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. Journal of Neuroscience 2002, 22(6):2343-2351.
36. Weber M., Hart J., Richardson R. Effects of d-cycloserine on extinction of learned fear to an olfactory cue. Neurobiology of Learning and Memory 2007, 87(4):476-482. http://dx.doi.org/10.1016/j.nlm.2006.12.010.
37. Werner-Seidler A., Richardson R. Effects of d-cycloserine on extinction: consequences of prior exposure to imipramine. Biological Psychiatry 2007, 62(10):1195-1197. 10.1016/j.biopsych.2007.04.010.
38. Wolpe W. Psychotherapy by reciprocal inhibition 1958, Stanford University Press, Palo Alto, CA.
39. Yamamoto S., Morinobu S., Fuchikami M., Kurata A., Kozuru T., Yamawaki S. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology 2008, 33(9):2108-2116. 10.1038/sj.npp.1301605.